InSite Vision, an ophthalmologic product manufacturer, announced Tim McInerney has been elected Chairman of its Board of Directors, according to a Yahoo news report.
Mr. McInerney has 25 years of experience in the investment and pharmaceutical industries and has been a member of the Board of Directors since 2008. He is also the Chairman of the Board's Nomination and Governance Committee as well as a member of the Board's Audit Committee. Mr. McInerney is currently a partner with Riverbank Capital Securities, an investment banking firm specializing in biotechnology and specialty pharmaceutical companies.
Related Articles on Ophthalmology:
Acuity Laser Eye and Vision Center's Dr. Steven Vale: Eye Surgery Should Be Limited to Physicians
Study: Use Grade 2 Reading Level, DVDs for Cataract Surgery Informed Consent
Nanoparticles to Deliver Steroids to the Retina
Mr. McInerney has 25 years of experience in the investment and pharmaceutical industries and has been a member of the Board of Directors since 2008. He is also the Chairman of the Board's Nomination and Governance Committee as well as a member of the Board's Audit Committee. Mr. McInerney is currently a partner with Riverbank Capital Securities, an investment banking firm specializing in biotechnology and specialty pharmaceutical companies.
Related Articles on Ophthalmology:
Acuity Laser Eye and Vision Center's Dr. Steven Vale: Eye Surgery Should Be Limited to Physicians
Study: Use Grade 2 Reading Level, DVDs for Cataract Surgery Informed Consent
Nanoparticles to Deliver Steroids to the Retina